Synopsis

Source of validity: Scientific
Rating (out of 5): 2

American Ginseng (Panax quinquefolius) has been studied for its potential effects on components of Metabolic Syndrome, which include insulin resistance, hyperglycemia, dyslipidemia, hypertension, and central obesity. Several small clinical studies and animal experiments have investigated its effects, particularly focusing on glycemic control. For example, some randomized controlled trials have shown that American Ginseng can modestly lower postprandial blood glucose levels in people with type 2 diabetes and, to a lesser extent, in those at risk of diabetes. These effects are thought to be mediated by ginsenosides, the main active constituents, which may influence insulin secretion and sensitivity.

However, evidence for improvement in other metabolic syndrome parameters (such as blood pressure, lipid profiles, and waist circumference) is limited and inconsistent. Systematic reviews and meta-analyses of available trials suggest that while American Ginseng may have a small beneficial effect on blood glucose, the overall quality of evidence is low due to small sample sizes, short study durations, and potential publication bias. There is also minimal support from traditional use specifically for metabolic syndrome; American Ginseng has more often been used as a general tonic in North American herbal medicine.

In summary, American Ginseng’s use for metabolic syndrome is supported by preliminary scientific evidence (mainly for glycemic control), but larger, rigorous trials are needed to confirm its efficacy and safety for this indication.

More about American Ginseng
More about Metabolic Syndrome

Other ingredients used for Metabolic Syndrome

Other health conditions supported by American Ginseng

Products containing American Ginseng